Rezlidhia

Rigel’s Rezlidhia (olutasidenib) Gets FDA Approval for Relapsed or Refractory AML
Xtalks
Wed, 12/7/22 - 09:53 am
Rigel Pharmaceuticals
Rezlidhia
olutasidenib
FDA
AML